iRhythm 

$155.73
23
+$1.22+0.79% Today

Statistics

Day High
160.99
Day Low
150.9
52W High
212
52W Low
92.52
Volume
436,754
Avg. Volume
550,068
Mkt Cap
5.02B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

19FebExpected
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Next
-1.48
-0.98
-0.49
0.01
Expected EPS
0.011087
Actual EPS
N/A

Financials

-19.14%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
1.18BRevenue
-226.58MNet Income

Analyst Ratings

$219.17Average Price Target
The highest estimate is 244.00.
From 12 ratings within the last 6 months. This is not an investment recommendation.
Buy
92%
Hold
8%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow IRTC. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbott Laboratories
ABT
Mkt Cap214.96B
Abbott Laboratories offers a broad range of medical devices, including cardiac monitors that compete with iRhythm's Zio patch.
Medtronic
MDT
Mkt Cap116.33B
Medtronic provides a variety of cardiac monitoring solutions, directly competing with iRhythm's offerings.
Bio-Rad Laboratories
BIO
Mkt Cap8.54B
Bio-Rad Laboratories, Inc. offers products and services in the field of clinical diagnostics and life science research, which includes technologies that can compete in the cardiac monitoring space.
Koninklijke Philips N.V.
PHG
Mkt Cap26.17B
Philips is a diversified health and well-being company, with a strong presence in the healthcare sector, including cardiac monitoring technologies.
Hologic
HOLX
Mkt Cap16.45B
Hologic, Inc. specializes in medical devices and diagnostics, with products that could compete in the broader market for cardiac health monitoring.
Masimo
MASI
Mkt Cap7.64B
Masimo Corporation offers medical technologies that are competitive in the patient monitoring space, including pulse oximetry and heart rate monitoring.
Dexcom
DXCM
Mkt Cap22.71B
DexCom, Inc. specializes in glucose monitoring systems but its expansion into broader health monitoring technologies positions it as a potential competitor.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific Corporation is a developer, manufacturer, and marketer of medical devices that are used in a range of interventional medical specialties, including cardiac monitoring.
Stryker
SYK
Mkt Cap136.19B
Stryker Corporation, a medical technologies firm, has a broad portfolio that could compete with iRhythm Technologies in the development of future cardiac or health monitoring solutions.

About

iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
Show more...
CEO
Mr. Quentin S. Blackford
Employees
2000
Country
US
ISIN
US4500561067

Listings

0 Comments

Share your thoughts

FAQ

What is iRhythm stock price today?
The current price of IRTC is $155.73 USD — it has increased by +0.79% in the past 24 hours. Watch iRhythm stock price performance more closely on the chart.
What is iRhythm stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange iRhythm stocks are traded under the ticker IRTC.
Is iRhythm stock price growing?
IRTC stock has fallen by -3.64% compared to the previous week, the month change is a -11.12% fall, over the last year iRhythm has showed a +43.07% increase.
What is iRhythm market cap?
Today iRhythm has the market capitalization of 5.02B
When is the next iRhythm earnings date?
iRhythm is going to release the next earnings report on February 19, 2026.
What were iRhythm earnings last quarter?
IRTC earnings for the last quarter are -0.16 USD per share, whereas the estimation was -0.32 USD resulting in a +50.64% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is iRhythm revenue for the last year?
iRhythm revenue for the last year amounts to 1.18B USD.
What is iRhythm net income for the last year?
IRTC net income for the last year is -226.58M USD.
How many employees does iRhythm have?
As of February 02, 2026, the company has 2,000 employees.
In which sector is iRhythm located?
iRhythm operates in the Health Care sector.
When did iRhythm complete a stock split?
iRhythm has not had any recent stock splits.
Where is iRhythm headquartered?
iRhythm is headquartered in San Francisco, US.